BCR‐ABL1 transcript levels at 4 weeks have prognostic significance for time‐specific responses and for predicting survival in chronic‐phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
Song, Hye‐young, Noh, Hayeon, Choi, Soo young, Lee, Sung‐Eun, Kim, Soo‐Hyun, Kee, Kyung‐Mi, Yoo, Hea‐Lyun, Lee, Mi‐young, Kang, Ki‐Hoon, Suh, Ji‐Hyung, Yang, Seon‐young, Jang, Eun‐Jung, Lee, Jangik I., Kim, Dong‐Wook
Published in Cancer medicine (Malden, MA) (01.10.2018)
Published in Cancer medicine (Malden, MA) (01.10.2018)
Get full text
Journal Article
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia
Yoo, Hea-Lyun, Kim, Soo-Hyun, Choi, Soo-Young, Lee, Sung-Eun, Kim, Dong-Wook
Published in Clinical lymphoma, myeloma and leukemia (01.07.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.07.2019)
Get full text
Journal Article
Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia
Lee, Sung-Eun, Choi, Soo Young, Oh, Yun Jeong, Kim, Soo-Hyun, Song, Hye-Young, Yoo, Hea-Lyun, Lee, Mi-Young, Chae, Moon-Jung, Kang, Ki-Hoon, Hwang, Hee-Jeong, Jang, Eun-Jung, Kim, Dong-Wook
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
BCR ‐ ABL 1 transcript levels at 4 weeks have prognostic significance for time‐specific responses and for predicting survival in chronic‐phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
Song, Hye‐young, Noh, Hayeon, Choi, Soo young, Lee, Sung‐Eun, Kim, Soo‐Hyun, Kee, Kyung‐Mi, Yoo, Hea‐Lyun, Lee, Mi‐young, Kang, Ki‐Hoon, Suh, Ji‐Hyung, Yang, Seon‐young, Jang, Eun‐Jung, Lee, Jangik I., Kim, Dong‐Wook
Published in Cancer medicine (Malden, MA) (01.10.2018)
Published in Cancer medicine (Malden, MA) (01.10.2018)
Get full text
Journal Article
BCR-ABL1 transcripts (MR 4.5 ) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
Lee, Sung-Eun, Choi, Soo Young, Kim, Soo-Hyun, Song, Hye-Young, Yoo, Hea-Lyun, Lee, Mi-Young, Kang, Ki-Hoon, Hwang, Hee-Jeong, Jang, Eun-Jung, Kim, Dong-Wook
Published in The Korean journal of internal medicine (01.01.2017)
Published in The Korean journal of internal medicine (01.01.2017)
Get full text
Journal Article
Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience
Lee, Sung-Eun, Choi, Soo Young, Kim, Soo-Hyun, Song, Hye-Young, Yoo, Hea-Lyun, Lee, Mi-Young, Kang, Ki-Hoon, Hwang, Hee-Jeong, Jang, Eun-Jung, Kim, Dong-Wook
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
BCR-ABL1 Transcript of 7.93% at 3 Months Is an Early Predictor for Long-Term Survival to Second-Line Therapy Using Next Generation Tyrosine Kinase Inhibitors in Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia
Lee, Sung-Eun, Choi, Soo Young, Oh, Yun Jeong, Kim, Soo-Hyun, Song, Hye-Young, Yoo, Hea-Lyun, Lee, Mi-Young, Chae, Moon-Jung, Kang, Ki-Hoon, Hwang, Hee-Jeong, Jang, Eun-Jung, Kim, Dong-Wook
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation
Kim, Hee-Je, Yoo, Hea-Lyun, Lee, Won-Sik, Kim, Hyeong-Joon, Kong, Jee Hyun, Choi, Yunsuk, Do, Young Rok, Kwak, Jae-Yong, Oh, Sukjoong, Kim, Sung Hyun, Kim, Jeong-A., Zang, Dae Young, Mun, Yeung-Chul, Won, Young-Woong, Lee, Sung-Eun, Kim, Dong-Wook
Published in Clinical lymphoma, myeloma and leukemia (01.10.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2017)
Get full text
Journal Article